Tunstall Supports Countrywide Approach to Transform the Lives of Three Million People with Telehealthcare

Tunstall HealthcareLeading telehealth and telecare services provider, Tunstall Healthcare, is supporting a new approach that aims to transform the lives of three million people with long-term conditions or social care needs, utilising telehealth and telecare within health and social care services.

Launched yesterday by the Minister of State for Care Services, Paul Burstow MP, '3millionlives' will enable millions of people to receive the significant benefits derived from a recently completed telehealth and telecare pilot, known as the Whole Systems Demonstrator (WSD) programme. The Minister re-affirmed his commitment to working with industry to improve the lives of millions of people today by publishing a Concordat with the four trade associations representing the telehealth and telecare industry.

Care Services Minister Paul Burstow said: "This new approach is set to improve the quality of care for 3 million people, increase their independence and dignity as well as reduce the time they spend in hospital. It is only by the telehealth industry working together with the Department of Health and other stakeholders, that this will be possible. In addition, UK industry will gain a competitive edge in a marketplace where many millions of people worldwide could benefit from this technology, helping to generate income and jobs in the UK."

The WSD programme was established by the Department of Health (DH) to evaluate how the use of telehealth and telecare services can support people with long-term health and care needs to live more independently. The three-year research project aimed to create the largest evidence base for telehealth and telecare in the world. Key findings from the WSD programme include a 15% reduction in A&E visits, a 20% reduction in emergency admissions, a 14% reduction in elective admissions, and a 45% reduction in mortality rates.

Tunstall's telehealthcare services are being used extensively in the WSD programme and is the only company with systems deployed in all 3 WSD sites Cornwall, Kent and Newham. The company's services enable patients to monitor their vital signs in their own homes easily, safely and securely and aids proactive case management, ensuring timely and appropriate support to patients.

Gil Baldwin, Vice Chair of the 3millionlives working group and CEO of Tunstall, said: "3millionlives is a fantastic example of industry and government working alongside each other to improve the lives of individuals living with long term conditions, enhancing clinical outcomes, supporting patients and doctors and saving money for the tax payer."

'3millionlives' will develop appropriate ways for the market to engage with stakeholders and commission telehealthcare at scale, and increase awareness and visibility of the potential benefits of telehealth and telecare globally, generating significant opportunities for UK plc.

The 3millionlives website is now live, and anyone interested in finding out more or becoming involved can find details at www.3millionlives.co.uk

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall's solutions support older people and those with long-term needs, helping them to live independently by effectively managing their health and well-being. Its solutions have been proven effective in the world's largest telehealthcare trial. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...